HC Wainwright & Co. Initiates Coverage On Traws Pharma with Buy Rating, Announces Price Target of $8
Benzinga Newsdesk 11 months ago
NewsPrice TargetInitiationAnalyst Ratings
HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Traws Pharma (NASDAQ:TRAW) with a Buy rating and announces Price Target of $8.
HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Traws Pharma (NASDAQ:TRAW) with a Buy rating and announces Price Target of $8.